KNTE - Kinnate Biopharma GAAP EPS of -$0.62 beats by $0.03 August, 11 2022 05:53 PM Kinnate Biopharma Inc. Kinnate Biopharma press release ( NASDAQ: KNTE ): Q2 GAAP EPS of -$0.62 beats by $0.03 . As of June 30, 2022, the total of cash and cash equivalents and investments was $279.6 million, exclusive of Kinnjiu’s cash. For further details see: Kinnate Biopharma GAAP EPS of -$0.62 beats by $0.03